MTOR and melanoma: Unlike a previous report (7), we found no change in mTOR signaling or autophagy induction in B16 melanoma cells treated with anti–PD-1 Ab (data not shown), and anti–PD-1 Ab + HCQ did not show any cytotoxicity in B16 melanoma cells in vitro (Supplemental Figure 1B).